NO20001219D0 - Blanding for medikament-administrasjon - Google Patents
Blanding for medikament-administrasjonInfo
- Publication number
- NO20001219D0 NO20001219D0 NO20001219A NO20001219A NO20001219D0 NO 20001219 D0 NO20001219 D0 NO 20001219D0 NO 20001219 A NO20001219 A NO 20001219A NO 20001219 A NO20001219 A NO 20001219A NO 20001219 D0 NO20001219 D0 NO 20001219D0
- Authority
- NO
- Norway
- Prior art keywords
- mixture
- drug administration
- administration
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9718986.4A GB9718986D0 (en) | 1997-09-09 | 1997-09-09 | Controlled release microsphere delivery system |
PCT/GB1998/002692 WO1999012549A2 (en) | 1997-09-09 | 1998-09-07 | Controlled release microsphere delivery system |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20001219D0 true NO20001219D0 (no) | 2000-03-09 |
NO20001219L NO20001219L (no) | 2000-03-09 |
Family
ID=10818687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20001219A NO20001219L (no) | 1997-09-09 | 2000-03-09 | Blanding for medikament-administrasjon |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1011680A2 (no) |
JP (1) | JP2001515862A (no) |
AR (1) | AR017079A1 (no) |
AU (1) | AU745511B2 (no) |
CA (1) | CA2302762A1 (no) |
GB (1) | GB9718986D0 (no) |
NO (1) | NO20001219L (no) |
NZ (1) | NZ502710A (no) |
WO (1) | WO1999012549A2 (no) |
ZA (1) | ZA987762B (no) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194006B1 (en) | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
US6495166B1 (en) | 1999-11-12 | 2002-12-17 | Alkermes Controlled Therapeutics Inc. | Apparatus and method for preparing microparticles using in-line solvent extraction |
US6331317B1 (en) | 1999-11-12 | 2001-12-18 | Alkermes Controlled Therapeutics Ii Inc. | Apparatus and method for preparing microparticles |
US6705757B2 (en) | 1999-11-12 | 2004-03-16 | Alkermes Controlled Therapeutics, Inc. Ii | Method and apparatus for preparing microparticles using in-line solvent extraction |
ES2169980B1 (es) * | 1999-12-17 | 2003-11-01 | Lipotec Sa | Microcapsulas para la liberacion prolongada de farmacos. |
US6264987B1 (en) | 2000-05-19 | 2001-07-24 | Alkermes Controlled Therapeutics Inc. Ii | Method for preparing microparticles having a selected polymer molecular weight |
US6495164B1 (en) | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
US6824822B2 (en) | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
US6471995B1 (en) | 2000-09-27 | 2002-10-29 | Alkermes Controlled Therapeutics, Inc. Ii | Apparatus and method for preparing microparticles using liquid-liquid extraction |
US20020114843A1 (en) | 2000-12-27 | 2002-08-22 | Ramstack J. Michael | Preparation of microparticles having improved flowability |
US8088726B2 (en) | 2002-06-25 | 2012-01-03 | Takeda Pharmaceutical Company Limited | Process for producing sustained-release composition |
CA2499132A1 (en) * | 2002-10-31 | 2004-05-13 | Pfizer Products Inc. | Solid and semi-solid polymeric ionic conjugates |
CN1870980B (zh) | 2003-10-23 | 2010-06-23 | 大冢制药株式会社 | 控释无菌阿立哌唑注射剂和方法 |
ES2375802T3 (es) | 2004-04-15 | 2012-03-06 | Alkermes Pharma Ireland Limited | Dispositivo de liberación sostenida a base de pol�?mero. |
BRPI0514753A (pt) | 2004-08-31 | 2008-06-24 | Pfizer Prod Inc | formas de dosagem farmacêutica compreendendo um medicamento de baixa solubilidade e um polìmero |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
DK2049081T3 (da) | 2006-08-09 | 2013-02-25 | Intarcia Therapeutics Inc | Osmotiske leveringssystemer og stempelarrangementer |
WO2008041245A2 (en) * | 2006-10-05 | 2008-04-10 | Panacea Biotec Ltd. | Injectable depot composition and it's process of preparation |
TWI481424B (zh) | 2006-12-18 | 2015-04-21 | Takeda Pharmaceutical | 緩釋性組成物及其製法 |
PT2157967E (pt) | 2007-04-23 | 2013-04-03 | Intarcia Therapeutics Inc | Formulações de suspensões de péptidos insulinotrópicos e suas utilizações |
HUE036214T2 (hu) | 2007-07-31 | 2018-06-28 | Otsuka Pharma Co Ltd | Eljárások aripiprazol-szuszpenzió és fagyasztva szárított készítmény elõállítására |
DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
KR102148624B1 (ko) | 2009-09-28 | 2020-08-26 | 인타르시아 세라퓨틱스 인코포레이티드 | 실질 항정상태 약물 전달의 신속 확립 및/또는 종결 |
ES2572948T3 (es) | 2010-11-25 | 2016-06-03 | Shan Dong Luye Pharmaceutical Co., Ltd. | Composiciones de rotigotina o sales farmacéuticamente aceptables de rotigotina |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
JO3410B1 (ar) | 2011-06-07 | 2019-10-20 | Otsuka Pharma Co Ltd | تركيبة أريبيبرازول مجفف بالتبريد |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
KR20240042548A (ko) | 2015-06-03 | 2024-04-02 | 인타르시아 세라퓨틱스 인코포레이티드 | 임플란트 배치 및 제거 시스템들 |
CN109310743A (zh) | 2016-05-16 | 2019-02-05 | 因塔西亚制药公司 | 胰高血糖素受体选择性多肽及其使用方法 |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
KR20190104039A (ko) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법 |
CA3057438A1 (en) | 2017-03-20 | 2018-09-27 | Teva Pharmaceuticals International Gmbh | Sustained release olanzapine formulaitons |
KR102045721B1 (ko) * | 2019-03-27 | 2019-11-18 | 주식회사 씨트리 | 아픽사반 함유 미립구 제조용 분산상의 조성물 및 이로부터 제조되는 생체적합성 고분자 기반 아픽사반 함유 미립구 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
DK0669128T3 (da) * | 1992-11-17 | 2000-06-19 | Yoshitomi Pharmaceutical | Sustained-release mikrosfære indeholdende antipsykotikum og fremgangsmåde til at fremstille samme |
IL117612A0 (en) * | 1995-03-24 | 1996-07-23 | Lilly Co Eli | Granule formulation for olanzapine |
-
1997
- 1997-09-09 GB GBGB9718986.4A patent/GB9718986D0/en not_active Ceased
-
1998
- 1998-08-26 ZA ZA9807762A patent/ZA987762B/xx unknown
- 1998-09-07 WO PCT/GB1998/002692 patent/WO1999012549A2/en not_active Application Discontinuation
- 1998-09-07 EP EP98941610A patent/EP1011680A2/en not_active Withdrawn
- 1998-09-07 JP JP2000510446A patent/JP2001515862A/ja active Pending
- 1998-09-07 CA CA002302762A patent/CA2302762A1/en not_active Abandoned
- 1998-09-07 AU AU89925/98A patent/AU745511B2/en not_active Ceased
- 1998-09-07 NZ NZ502710A patent/NZ502710A/en unknown
- 1998-09-09 AR ARP980104487A patent/AR017079A1/es unknown
-
2000
- 2000-03-09 NO NO20001219A patent/NO20001219L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999012549A3 (en) | 1999-05-06 |
WO1999012549A2 (en) | 1999-03-18 |
JP2001515862A (ja) | 2001-09-25 |
AU8992598A (en) | 1999-03-29 |
GB9718986D0 (en) | 1997-11-12 |
CA2302762A1 (en) | 1999-03-18 |
AU745511B2 (en) | 2002-03-21 |
NO20001219L (no) | 2000-03-09 |
EP1011680A2 (en) | 2000-06-28 |
AR017079A1 (es) | 2001-08-22 |
ZA987762B (en) | 2000-02-28 |
NZ502710A (en) | 2001-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20001219D0 (no) | Blanding for medikament-administrasjon | |
NO994003L (no) | Farmasoytisk blanding | |
NO975931D0 (no) | Blanding for administrering av medikament | |
ID23874A (id) | Obat | |
NO992427D0 (no) | Farmas°ytisk blanding | |
ID24654A (id) | Formulasi farmasi omeprazola | |
FI972292A0 (fi) | Administrering av diabetes | |
DK0797991T3 (da) | Lægemiddelformulering med forhalet frigivelse | |
DK1035833T3 (da) | Sammensætning til nasal indgivelse | |
EE9700241A (et) | Farmatseutiline kompositsioon transdermaalseks manustamiseks | |
DE69821457D1 (de) | Zusammensetzungen mit kontrollierter Wirkstoffabgabe | |
DK0998272T3 (da) | Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum | |
PL328399A1 (en) | Drug administration aid | |
DE69935681D1 (de) | Vorrichtungen zur Medikamentverabreichung | |
FI971279A (fi) | Lääkkeitä | |
KR950700754A (ko) | 신규의 약물(novel medicament) | |
NO20001014L (no) | Dermatologisk blanding | |
BR9610396A (pt) | Formulação farmacêutica | |
FR2767121B1 (fr) | Distributeur de medicaments | |
DE69810189D1 (de) | Zusammensetzungen mit kontrollierter Wirkstoffabgabe | |
NO995251D0 (no) | FremgangsmÕte for administrering av haloterapi | |
IS5331A (is) | Ný lyfjablanda | |
DK0868911T3 (da) | Rapamycinpræparater til oral indgivelse | |
NO995039L (no) | Gastrisk bibeholdt farmasoeytisk preparat | |
NO992999D0 (no) | Farmas°ytisk blanding for oral administrering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |